Taisho Pharmaceutical Holdings Co., Ltd.

TAISF · OTC
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Assets
Cash & Equivalents$246,071$240,479$248,189$255,966
Short-Term Investments$20,296$20,278$20,231$200
Receivables$72,558$73,465$58,619$52,300
Inventory$63,939$62,773$58,319$53,331
Other Curr. Assets$13,913$12,812$17,976$14,083
Total Curr. Assets$416,777$409,807$403,334$375,880
Property Plant & Equip (Net)$149,027$149,024$143,194$141,170
Goodwill$134,782$136,733$129,292$128,051
Intangibles$112,748$114,881$110,824$110,441
Long-Term Investments$167,617$146,045$171,362$163,216
Tax Assets$7,875$6,959$8,324$6,761
Other NC Assets$16,637$36,659-$4$15,968
Total NC Assets$588,686$590,301$562,992$565,607
Other Assets$0$3$5$3
Total Assets$1,005,463$1,000,111$966,331$941,490
Liabilities
Payables$13,535$14,876$14,979$15,101
Short-Term Debt$0$0$0$1,792
Tax Payable$4,270$4,219$3,460$1,889
Deferred Revenue$0$0$0$209
Other Curr. Liab.$60,051$59,131$59,318$52,887
Total Curr. Liab.$80,824$79,600$79,508$73,778
LT Debt$0$0$0-$350
Deferred Rev, NC$0$0$0$350
Deferred Tax Liab, NC$41,368$41,374$36,890$32,801
Other NC Liab.$25,972$22,836$25,533$25,568
Total NC Liab.$67,340$64,210$62,423$58,369
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$148,164$143,810$141,931$132,147
Equity
Pref Stock$0$0$722,930$0
Common Stock$30,000$30,000$30,000$30,000
Retained Earnings$715,857$717,087$714,000$713,776
AOCI$107,393$105,504$78,876$63,853
Other Equity-$21,160-$21,076-$744,000-$21,062
Total Equity$832,090$831,515$801,806$786,567
Supplemental Information
Minority Interest$25,206$24,786$22,594$22,776
Total Liab. & Tot. Equity$1,005,460$1,000,111$966,331$941,490
Net Debt-$246,071-$240,479-$248,189-$254,524
Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) Financial Statements & Key Stats | AlphaPilot